http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021063054-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e75dbe74a46e1e3af10225913a7bfb4b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate | 2019-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c22ccc69155f7be38b7a9849724a99e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b05892991c5e38b48a064ec547aee3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae28e87e86fd0307d9da27d30dd7c3bb |
| publicationDate | 2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021063054-A |
| titleOfInvention | Fluorosalidemide derivatives and pharmaceutical compositions |
| abstract | PROBLEM TO BE SOLVED: To provide 2- (3-fluoro-2,6-dioxopiperidine-3-yl) 4-hydroxyisoindoline-1,3-dione and 2- (3-), which are assumed to be in vivo oxides of fluorothalidomide. To produce and provide fluoro-2,6-dioxopiperidine-3-yl) 5-hydroxyisoindoline-1,3-dione. SOLUTION: A derivative represented by the structural formulas (A) and (B), a salt thereof, or a solvate thereof. (In the formula: R1, R2, and R3 are the same or different, hydrogen atom, lower alkyl group, lower alkoxy group, etc., R4 is hydrogen atom or optionally substituted silyl, etc .; R5 is hydrogen atom or It is hydroxy or the like that may be substituted.) [Selection diagram] Fig. 1 |
| priorityDate | 2019-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.